HLA class I, II & III genes in confirmed late-onset Alzheimer’s disease
暂无分享,去创建一个
K. Morgan | A. Smith | D. Lehmann | D. Warden | H. Wiebusch | S. Marshall | C. Johnston | K. Schappert | J. Poirier | J. Xuereb | N. Kalsheker | K. Welsh | Kevin Morgan | Noor Kalsheker | Carole Johnston | Judes Poirier | J. H. Xuereb
[1] Das Rückenmuskelphänomen beim Sprechen. , 1906 .
[2] D. Bell,et al. Alzheimer's disease and HLA. , 1978, Tissue antigens.
[3] Histocompatibility Antigens in Alzheimer’s Disease , 1980 .
[4] HLA antigens in senile dementia and multiple infarct dementia. , 1981, Age and ageing.
[5] C. Eisdorfer,et al. Histocompatibility antigens (HLA) and patterns of cognitive loss in dementia of the Alzheimer type , 1981, Neurobiology of Aging.
[6] Lack of association between Alzheimer's disease and histocompatibility antigens. , 2008, Tissue antigens.
[7] HLA antigens in Alzheimer's disease. , 2008, Tissue antigens.
[8] E. Renvoize. An HLA and family study of Alzheimer's disease , 1984, Psychological Medicine.
[9] G. Small,et al. HLA-A2 as a possible marker for early-onset Alzheimer disease in men , 1986, Neurobiology of Aging.
[10] H. Endo,et al. HLA system in senile dementia of Alzheimer type and multi-infarct dementia in Japan. , 1986, Archives of gerontology and geriatrics.
[11] M. Roth. CAMDEX : the Cambridge examination for mental disorders of the elderly , 1999 .
[12] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[13] PhilipR. Wenham,et al. Apolipoprotein E genotyping by one-stage PCR , 1991, The Lancet.
[14] A. D. Roses,et al. Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .
[15] M. Frecker,et al. Immunological Associations in Familial and Non-Familial Alzheimer Patients and Their Families , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[16] H. Hsieh-Li,et al. Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. , 1994, Cellular immunology.
[17] M. Barnardo,et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.
[18] D. Premkumar,et al. Molecular aspects of inflammatory and immune responses in Alzheimer's disease , 1996, Neurobiology of Aging.
[19] F. S. Jensen,et al. Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site. , 1996, Human heredity.
[20] Patrick L. McGeer,et al. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease , 1996, Neurology.
[21] Douglas Walker,et al. Inflammation and Alzheimer's disease pathogenesis , 1996, Neurobiology of Aging.
[22] I. McKeith,et al. HLA‐DR antigens associated with major genetic risk for late‐onset Alzheimer's disease , 1997, Neuroreport.
[23] K. Welsh,et al. Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin , 1997 .
[24] R. Mahley,et al. Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates β-amyloid protein activation of complement in vitro , 1997, Brain Research.
[25] A. Smith,et al. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. , 1997, Human molecular genetics.
[26] G. Schellenberg,et al. Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease , 1997, Neurology.
[27] M. Barnardo,et al. High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology. , 1996, Tissue antigens.
[28] A. Oterino,et al. Short communication Association of the HLA‐A2 allele with an earlier age of onset of Alzheimer's disease , 1998 .
[29] D. Laskowitz,et al. Endogenous apolipoprotein E suppresses LPS‐stimulated microglial nitric oxide production , 1998, Neuroreport.
[30] J. Haines,et al. No association between the HLA-A2 allele and Alzheimer disease , 1999, Neurogenetics.
[31] S. Sorbi,et al. HLA A2 allele is associated with age at onset of Alzheimer's disease , 1999, Annals of neurology.
[32] H. Wiebusch,et al. Further evidence for a synergistic association between APOEɛ4 and BCHE-K in confirmed Alzheimer’s disease , 1999, Human Genetics.
[33] K. Morgan,et al. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease , 1999, European Journal of Human Genetics.
[34] P. Ince,et al. Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03 , 1999, Neuroscience Letters.
[35] P. Ince,et al. Frequency of HLA-A and B alleles in early and late-onset Alzheimer's disease , 1999, Neuroscience Letters.